>
Company >
History
-
2021
-
Sep.
Signed a non-cxclusive license agreement with Immunovia(Sweden)
for the patent 'diagnostic biomarker of pancreatic cancer'
-
Aug.
World's 1st Europeon&Chinese patent
registration of diagnostic technique for sepsis
-
Jan.
Equity invesrment to 'Onebiomed',
a Singapore molecular diagnostic company
-
2020
-
Feb.
Obtainment of a US patent for an early diagnosis
technology of pancreatic cancer
-
Jul.
Obtainment of the patents for a diagnosis
technology of septicemia both in US and Japan
-
2019
-
Oct.
Exclusive supply contract with JEOL biochemical equipment
-
2018
-
Nov.
Launched SANGRAY, the first X-ray blood irradiator in Korea
-
Sep.
Released steam sterilizers JW-SS360, JW-SS270
-
Mar.
Early detection of pancreatic cancer "Multiple biomarker diagnostic kit" Technology transfer contract signed (Yonsei University)
-
2016
-
May.
Signed a contract for early diagnosis of sepsis infection technology transfer ((Re)Pharmaceutical Bioconvergence Research Group)
-
Apr.
Established JW Bioscience
